Drug Interactions between Advair Diskus and carvedilol
This report displays the potential drug interactions for the following 2 drugs:
- Advair Diskus (fluticasone/salmeterol)
Interactions between your drugs
Applies to: Advair Diskus (fluticasone / salmeterol) and carvedilol
Using carvedilol together with salmeterol may reduce the benefits of both medications, since they have opposing effects in the body. In addition, carvedilol can sometimes cause narrowing of the airways, which may worsen your breathing problems or trigger severe asthmatic attacks. Carvedilol is normally not recommended if you have asthma, a history of asthma, or severe chronic obstructive pulmonary disease (COPD). Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact or are less likely to interact. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Applies to: Advair Diskus (fluticasone / salmeterol) and Advair Diskus (fluticasone / salmeterol)
Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
For clinical details see professional interaction data.
Drug and food interactions
No interactions were found. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|